Related references
Note: Only part of the references are listed.Does Strong Analgesic' Equal Strong Opioid'? Tapentadol and the Concept of μ-Load'
Robert B. Raffa et al.
ADVANCES IN THERAPY (2018)
Efficacy and safety of tapentadol prolonged release formulation in the treatment of elderly patients with moderate-to-severe chronic osteoarthritis knee pain: a pooled analysis of two double-blind, randomized, placebo-, and active-controlled trials
Bernd Lange et al.
CURRENT MEDICAL RESEARCH AND OPINION (2018)
Review of Post-Marketing Safety Data on Tapentadol, a Centrally Acting Analgesic
Ariane Stollenwerk et al.
ADVANCES IN THERAPY (2018)
Tapentadol Prolonged Release for Chronic Pain: A Review of Clinical Trials and 5 Years of Routine Clinical Practice Data
Ralf Baron et al.
PAIN PRACTICE (2017)
Efficacy and safety of tapentadol prolonged release for moderate-to-severe chronic osteoarthritis knee pain: a pooled analysis of two double-blind, randomized, placebo- and oxycodone controlled release-controlled studies
Bernd Lange et al.
CURRENT MEDICAL RESEARCH AND OPINION (2017)
Long-term Safety and Efficacy of Tapentadol Extended Release Following up to 2 Years of Treatment in Patients With Moderate to Severe, Chronic Pain: Results of an Open-label Extension Trial
Robert Buynak et al.
CLINICAL THERAPEUTICS (2015)
Tapentadol prolonged release for severe chronic cancer-related pain: effectiveness, tolerability, and influence on quality of life of the patients
Artur Schikowski et al.
JOURNAL OF PAIN RESEARCH (2015)
The Mu-Opioid Receptor Agonist/Noradrenaline Reuptake Inhibition (MOR-NRI) Concept in Analgesia: The Case of Tapentadol
Thomas M. Tzschentke et al.
CNS DRUGS (2014)
Management of severe chronic pain with tapentadol prolonged release - long-term data from pain specialists
Volker Strick
CURRENT MEDICAL RESEARCH AND OPINION (2014)
Effectiveness and Tolerability of Tapentadol Prolonged Release Compared With Prior Opioid Therapy for the Management of Severe, Chronic Osteoarthritis Pain
Ilona Steigerwald et al.
CLINICAL DRUG INVESTIGATION (2013)
The societal burden of pain in Germany: Health-related quality-of-life, health status and direct medical costs
Paul C. Langley
JOURNAL OF MEDICAL ECONOMICS (2012)
Effectiveness and safety of tapentadol prolonged release with tapentadol immediate release on-demand for the management of severe, chronic osteoarthritis-related knee pain: results of an open-label, phase 3b study
Ilona Steigerwald et al.
Journal of Pain Research (2012)
Efficacy and Safety of Tapentadol Extended Release Compared with Oxycodone Controlled Release for the Management of Moderate to Severe Chronic Pain Related to Osteoarthritis of the Knee A Randomized, Double-Blind, Placebo- and Active-Controlled Phase III Study
Marc Afilalo et al.
CLINICAL DRUG INVESTIGATION (2010)
Long-term Safety and Tolerability of Tapentadol Extended Release for the Management of Chronic Low Back Pain or Osteoarthritis Pain
James E. Wild et al.
PAIN PRACTICE (2010)
Share Paper
